Mirum Company Profile
What is the competitive landscape for MIRUM
MIRUM has five approved drugs.
There are ten US patents protecting MIRUM drugs.
Summary for Mirum
| US Patents: | 10 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Mirum
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-002 | Apr 10, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mirum | LIVMARLI | maralixibat chloride | SOLUTION;ORAL | 214662-002 | Jul 24, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mirum | LIVMARLI | maralixibat chloride | SOLUTION;ORAL | 214662-001 | Sep 29, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-002 | Apr 10, 2025 | RX | Yes | Yes | 11,260,053 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Mirum Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 7592606 | ⤷ Start Trial |
| European Patent Office | 2575821 | ⤷ Start Trial |
| Finland | C20230019 | ⤷ Start Trial |
| Norway | 2023023 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Mirum Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2771003 | 2023C/521 | Belgium | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT, OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, EN PARTICULIER LE CHLORURE DE MARALIXIBAT; AUTHORISATION NUMBER AND DATE: EU/1/22/1704 20221212 |
| 2771003 | C02771003/01 | Switzerland | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 69201 18.07.2024 |
| 1392714 | 1790020-0 | Sweden | ⤷ Start Trial | PRODUCT NAME: OBETICHOLIC ACID; REG. NO/DATE: EU/1/16/1139 20161215 |
| 2380576 | 2020/043 | Ireland | ⤷ Start Trial | PRODUCT NAME: DEOXYCHOLIC ACID SODIUM SALT; NAT REGISTRATION NO/DATE: PA2103/003/001 20170602; FIRST REGISTRATION NO/DATE: SE/H/1547/001/DC 20160729 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
